Alliance Pharma’s Acquisition of LGC’s Development Solutions Business

Ashurst has advised LGC on the deal.LGC sold its drug development solutions (DDS) business to Alliance Pharma, a US-based bioanalytical contract research organisation and an Ampersand…

This content is for Standard 1 Year members only.
Login Join Now
Giulia Di Palma

Author: Giulia Di Palma

This content is for Standard 1 Year members only.
Login Join Now